World OTC Pharmaceutical Markets

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

• Background
• Scope and Methodology
• Size and Growth of the Market
• Key Issues and Trends Affecting Market
• Leading Competitors

CHAPTER TWO: INTRODUCTION

• Background
• Distribution and Safety Issues in the United States
• Consumer Advertising/Promotion
• World Health and Life Expectancy
  • Life Expectancy
  • Birth Rates
  • Tobacco Use
  • Obesity
• Declining Growth of the World Population
• Prescription VS Over-the-Counter Industry
  • Rx-to-OTC Switch Industry
  • Rx-to-OTC Switch Forecast in the United States
  • Economic Trends
    • Purchasing Power Trends
    • Challenges
  • Health Insurance Issues and Trends
  • Consumer Issues and Trends
    • U.S Consumers
    • Consumers around the World
  • Access to Professional Medical Services and the Link to Self-Medication
  • Regulatory Environment
    • Revisions to Pharmaceutical Affairs Law (PAL) in Japan
    • Russian Beneficiary Drug Provision Program
    • A Third Class of Drugs in the United States

CHAPTER THREE: OTC MARKETS IN ASIA-PACIFIC AND AFRICA

• Overview
• Demographics
• OTC Product Segments
• Market Analysis
• OTC Product Segment Market Analysis
• Markets by Country

CHAPTER FOUR: OTC MARKETS IN EUROPE

• Overview
• Demographics
• OTC Product Segment
• Market Analysis
• OTC Product Segment Market Analysis
• Markets by Country

CHAPTER FIVE: OTC MARKETS IN NORTH AMERICA

• Overview
• Demographics
• OTC Product Segments
• Market Analysis
• OTC Product Segment Market Analysis
• Markets by Country

CHAPTER SIX: OTC MARKETS IN SOUTH AMERICA

• Overview
• Demographics
• OTC Product Segments
• Market Analysis
  • OTC Product Segment Market Analysis
  • Markets by Country

CHAPTER SEVEN: SUMMARY OF WORLD OTC MARKETS

• Overview
  • OTC Product Segment Market Analysis
  • Markets by Country

CHAPTER EIGHT: LEADING OTC MANUFACTURERS

• Overview
• Competitor Analysis
• Significant Mergers and Acquisitions
• Bristol-Myers Squibb and Novartis AG
• Johnson & Johnson and Pfizer
• Bayer and Roche
• Reckitt Benckiser and Adams Respiratory Therapeutics
• Reckitt Benckiser and Boots Healthcare
• Leading Corporate Profiles
• Bayer Healthcare AG
• Boehringer Ingelheim Gmbh
• Chattem, Inc.
• Glaxo Smith Kline
• Mc Neil Consumer (Johnson & Johnson)
• Novartis Consumer
• Procter & Gamble
• Reckitt Benckiser
• Sanofi-Aventis
• Schering-Plough
• Taisho Pharmaceutical
• Takeda Pharmaceutical
• Wyeth

APPENDIX: LIST OF MAJOR COMPANIES

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

• Table 1-1: Total World OTC Market Analysis, 2005-2007
• Table 1-2: Forecasted Total World OTC Market Analysis: 2008-2012
• Figure 1-1: Total World OTC Market Analysis: 2005-2012

CHAPTER TWO: INTRODUCTION

• Table 2-1: Average Life Expectancy in Years by Country 1980, 2004 and Estimated 2006
• Table 2-2: Crude Birth Rate per 1,000 Persons 2000, 2005 and Projected 2010
• Figure 2-1: Crude Birth Rate per 1,000 Persons 2000, 2005 and Projected 2010
• Table 2-3: Percent of Smokers by Country
• Figure 2-2: Average Percent of Smokers Worldwide in Developed Regions
• Table 2-4: Percent of Population that is Obese* in 2003, 2004 and Estimated 2005
• Table 2-5: World Population 1980 to 2050
• Figure 2-3: World Population 1980 to 2050
• Table 2-6: Total Pharmaceutical Markets, Prescription vs. Non-Prescription by Region, 2007
• Figure 2-4: Total Pharmaceutical Markets, Prescription vs. Non-Prescription by Region, 2007
• Table 2-7: Leading FDA Approved Rx-to-OTC Switches, 1994-2007
• Figure 2-5: Number of New Rx-to-OTC Switches in the United States, per Year 1976-2007
• Table 2-8: Potential Rx-to-OTC Switches, 2008-2013
• Table 2-9: Total Healthcare Expenditures as a Percent of GDP by Country 2004 and 2006
• Figure 2-6: Total Healthcare Expenditures as a Percent of GDP by Country 2004 and 2006
• Table 2-10: Gross National Income Comparison by Country 2000-2005
• Figure 2-7: Gross National Income Growth by Country 2000-2005
• Table 2-11: National Healthcare Expenditures in the United States 1960-2010
• Figure 2-8: Healthcare Spending as a Percent of GDP in the United States
• Table 2-12: Health Insurance Trends in the United States 2003-2006
• Figure 2-9: Typical Pharmacist-Consumer OTC Drug Counseling Session

CHAPTER THREE: OTC MARKETS IN ASIA- PACIFIC AND AFRICA

• Table 3-1: Population by Age Group for the Five Most Populated Countries in Asia-Pacific, Estimated 2007
• Table 3-2: Population by Age Group for the Five Most Populated Countries in Asia-Pacific, Projected 2012
• Figure 3-1: Population for the Five Most Populated Countries in Asia-Pacific, Estimated 2007 and Projected 2012
• Table 3-3: Population by Age Group for Africa, Estimated 2007 and 2012
• Figure 3-2: Population for Africa, Estimated 2007 and Projected 2012
• Table 3-4: Population by Gender for the Five Most Populated Countries in Asia-Pacific, Estimated 2007 and Projected 2012
• Figure 3-3: Population by Gender for Asia-Pacific, Estimated 2007 and Projected 2012
• Table 3-5: Population by Gender for Africa, Estimated 2007 and Projected 2012
• Figure 3-4: Population by Gender for Africa, Estimated 2007 and Projected 2012
• Table 3-6: Examples of Marketed OTC Products in Asia-Pacific and Africa (Product Name by Type and Marketer)
• Table 3-7: Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2007 and 2012
• Figure 3-5: Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2007
• Figure 3-6: Asia-Pacific/Africa OTC Market as a Percentage of World Market, 2012
• Table 3-8: Asia-Pacific/Africa OTC Market Analysis, 2005-2007
• Table 3-9: Forecasted Asia-Pacific/Africa OTC Market Analysis: 2008-2012
• Figure 3-7: Asia-Pacific/Africa OTC Market Analysis: 2005-2012
• Table 3-10: Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2005-2007
• Table 3-11: Forecasted Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2008-2012
• Figure 3-8: Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2005-2012
• Figure 3-9: Asia-Pacific/Africa OTC Market Analysis by Product Segment, 2007
• Table 3-12: Asia-Pacific/Africa OTC Market Analysis by Selected Country, 2007
• Figure 3-10: Asia-Pacific/Africa OTC Market Analysis by Selected Country, 2007

CHAPTER FOUR: OTC MARKETS IN EUROPE

• Table 4-1: Population by Age for the Five Most Populated Countries in Europe, Estimated 2007
• Table 4-2: Population by Age for the Five Most Populated Countries in Europe, Projected 2012
• Figure 4-1: Population for the Five Most Populated Countries in Europe, Estimated 2007 and Projected 2012
• Table 4-3: Population by Gender for the Five Most Populated Countries in Europe, Estimated 2007 and Projected 2012
• Figure 4-2: Population by Gender for Europe, Estimated 2007 and Projected 2012
• Table 4-4: Examples of Marketed OTC Products in Europe (Product Name by Type and Marketer)
• Table 4-5: European OTC Market as a Percentage of World Market, 2007 and 2012
• Figure 4-3: European OTC Market as a Percentage of World Market, 2007
• Figure 4-4: European OTC Market as a Percentage of World Market, 2012
• Table 4-6: European OTC Market Analysis, 2005-2007
• Table 4-7: Forecasted European OTC Market Analysis: 2008-2012
• Figure 4-5: European OTC Market Analysis: 2005-2012
• Table 4-8: European OTC Market Analysis by Product Segment, 2005-2007
• Table 4-9: Forecasted European OTC Market Analysis by Product Segment, 2008-2012
• Figure 4-6: European OTC Market Analysis by Product Segment, 2005-2012
• Figure 4-7: European OTC Market Analysis by Product Segment, 2007
• Table 4-10: European OTC Market Analysis by Selected Country, 2007
• Figure 4-8: European OTC Market Analysis by Selected Country, 2007

CHAPTER FIVE: OTC MARKETS IN NORTH AMERICA

• Table 5-1: Population by Age for the Five Most Populated Countries in North America, Estimated 2007
• Table 5-2: Population by Age for the Five Most Populated Countries in North America, Projected 2012
• Figure 5-1: Population for the Five Most Populated Countries in North America, Estimated 2007 and Projected 2012
• Table 5-3: Population by Gender for the Five Most Populated Countries in North America, Estimated 2007 and Projected 2012
• Figure 5-2: Population by Gender for North America, Estimated 2007 and Projected 2012
• Table 5-4: Examples of Marketed OTC Products in North America (Product Name by Type and Marketer)
• Table 5-5: North American OTC Market as a Percentage of World Market, 2007 and 2012
• Figure 5-3: North American OTC Market as a Percentage of World Market, 2007
• Figure 5-4: North American OTC Market as a Percentage of World Market, 2012
• Table 5-6: North American OTC Market Analysis, 2005-2007
• Table 5-7: Forecasted North American OTC Market Analysis: 2008-2012
• Figure 5-5: North American OTC Market Analysis: 2005-2012
• Table 5-8: North American OTC Market Analysis by Product Segment, 2005-2007
• Table 5-9: Forecasted North American OTC Market Analysis by Product Segment, 2008-2012
• Figure 5-6: North American OTC Market Analysis | by Product Segment, 2005-2012
• Figure 5-7: North American OTC Market Analysis by Product Segment, 2007
• Table 5-10: North American OTC Market Analysis by Selected Country, 2007
• Figure 5-8: North American OTC Market Analysis by Selected Country, 2007

CHAPTER SIX: OTC MARKETS IN SOUTH AMERICA

• Table 6-1: Population by Age for the Five Most Populated Countries in South America, Estimated 2007
• Table 6-2: Population by Age for the Five Most Populated Countries in South America, Projected 2012
• Figure 6-1: Population for the Five Most Populated Countries in South America, Estimated 2007 and Projected 2012
• Table 6-3:Population by Gender for the Five Most Populated Countries in South America, Estimated 2007 and Projected 2012
• Figure 6-2: Population by Gender for South America, Estimated 2007 and Projected 2012
• Table 6-4: Examples of Marketed OTC Products in South America (Product Name by Type and Marketer)
• Table 6-5: South American OTC Market as a Percentage of World Market, 2007 and 2012
• Figure 6-3: South American OTC Market as a Percentage of World Market, 2007
• Figure 6-4: South American OTC Market as a Percentage of World Market, 2012
• Table 6-6: South American OTC Market Analysis, 2005-2007
• Table 6-7: Forecasted South American OTC Market Analysis: 2008-2012
• Figure 6-5: South American OTC Market Analysis: 2005-2012
• Table 6-8: South American OTC Market Analysis by Product Segment, 2005-2007
• Table 6-9: Forecasted South American OTC Market Analysis by Product Segment, 2008-2012
• Figure 6-6: South American OTC Market Analysis by Product Segment, 2005-2012
• Figure 6-7: South American OTC Market Analysis by Product Segment, 2007
• Table 6-10: South American OTC Market Analysis by Selected Country, 2007
• Figure 6-8: South American OTC Market Analysis by Selected Country, 2007

CHAPTER SEVEN: SUMMARY OF WORLD OTC MARKETS

• Table 7-1: Total World OTC Market Analysis, 2005-2007
• Table 7-2: Forecasted Total World OTC Market Analysis: 2008-2012
• Figure 7-1: Total World OTC Market Analysis: 2005-2012
• Table 7-3: Total World OTC Market Analysis by Product Segment, 2005-2007
• Table 7-4: Forecasted Total World OTC Market Analysis by Product Segment, 2008-2012
• Figure 7-2: Total World OTC Market Analysis by Product Segment, 2005-2012
• Figure 7-3: Total World OTC Market Analysis by Product Segment, 2007
• Figure 7-4: Total World OTC Market Analysis by Product Segment, 2012
• Table 7-5: Top Ten World OTC Markets by Country, 2007
• Figure 7-5: Top Ten World OTC Markets by Country, 2007

CHAPTER EIGHT: LEADING OTC MANUFACTURERS

• Table 8-1: Leading Suppliers Shares of the OTC Market and Significant Segments of Participation, 2007
• Figure 8-1: Leading Suppliers Shares of the OTC Market, 2007